Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6–4.0 ng/mL range of total PSA OBJECTIVETo compare the performance of complexed prostate-specific antigen (cPSA) to total PSA (tPSA) and percentage free PSA (f/tPSA) in the diagnosis of ... J.,Kellogg...
391 Incidence and clinical importance of prostate cancer in total PSA range 1–4 ng/ml — data of prospective screening trialdoi:10.1016/S1569-9056(04)90389-2M. Kwiatkowski and K. Lehmann and A. Huber and B. Stamm and F. Recker
Is additional testing necessary in men with prostate-specific antigen levels of 1.0 μg/L or less in a population-based screening setting? (ERSPC, section Rotterdam). Urology 2005;65(2):343-346. 31. Soletormos G, Semjonow A, Sibley PE. Biological variation of total prostate-specific ...
所有患者均接受经直肠超声检查(transrectal ultrasonography,TRUS)引导下会阴前列腺穿刺活检。纳入标准:① 血清总PSA(total PSA,t-PSA)为4~10 ng/mL;② 穿刺前均接受TRTE和mpMRI检查;③ 已签署知情同意书,能耐受穿刺活检术且有明确诊断结果。排...
As the proportion of fPSA decreases, the probability of prostate cancer increases (Polascik et al., 1999). The fPSA is used to increase the sensitivity of the PSA screening in the range of 2–4 ng/ml. Furthermore, fPSA improves the specificity of PSA screening in the range of 4–10 ...
PSA testing for cancer screening may help detect prostate cancer early, when it's easier to treat and more likely to be curable. Testing can be done with a simple and widely available blood test. Some people prefer to know one way or the other if they have prostate cancer. ...
What is the controversy surrounding PSA screening? 1) Could lead to overtreatment Using the PSA test to screen for prostate cancer may help to detect small tumors, but many of these tumors do not cause symptoms and will grow so slowly that they are unlikely to be life-threatening. ...
Objectives The range and use of ultrasound fetal measurements have gradually been extended. Measurements have been combined to estimate fetal weight by mat... NJ Dudley - 《Ultrasound in Obstetrics & Gynecology》 被引量: 762发表: 2005年 Variability of measured resting metabolic rate. The necessity...
Prostate-specific antigen (PSA) screening has potential to reduce prostate cancer mortality but frequently detects prostate cancer that is not clinically important. 前列腺特异性抗原(PSA)筛查有可能降低前列腺癌症死亡率,但经常检测到...
There was a wide range of countries and study sizes. One study focused on a symptomatic cohort within a population screening study, and the remainder were set in hospital urology clinics. No study was performed in a primary care population. Five studies gathered stage and grade data. All but...